B of A Securities analyst Andrew Obin downgrades Vontier (NYSE:VNT) from Buy to Neutral.
Novo Nordisk’s Ozempic And Wegovy Helps Lose Weight, Not One’s Mind: US Study Find No Increased Suicidal Thoughts Risk
On Friday, a comprehensive U.S.
B of A Securities Downgrades Vontier to Neutral
B of A Securities analyst Andrew Obin downgrades Vontier (NYSE:VNT) from Buy to Neutral.
Related Posts
10 Analysts Have This to Say About Merus
Within the last quarter, Merus (NASDAQ:MRUS) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…
Alphabet Misses On Q3 Revenue, EPS; YouTube, Network Revenue Decline. Here’s What’s Next
Technology giant Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) reported third-quarter financial results after
Assessing Rockwell Automation: Insights From 4 Financial Analysts
In the last three months, 4 analysts have published ratings on Rockwell Automation (NYSE:ROK), offering a diverse range…